Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. May 15, 2019; 11(5): 416-423
Published online May 15, 2019. doi: 10.4251/wjgo.v11.i5.416
Table 4 Univariate and Multivariate analyses of clinicopathologic factors associated with overall survival
5-yr OS (%)Univariate
Multivariate
Hazard ratioP valueHazard ratioP value
Sex: Male vs female49.4 vs 66.73.352 (0.420-26.755)0.229--
Age: < 65 yr vs ≥ 65 yr63.5 vs 44.70.597 (0.199-1.796)0.354--
Tumor location: Anastomotic vs nonanastomotic57.7 vs 56.20.868 (0.265-2.846)0.816--
Interval: < 5 yr vs ≥ 5 yr56.8 vs 55.40.665 (0.213-2.074)0.479--
Operation type: Completion gastrectomy vs segmental resection56.2 vs 68.62.112 (0.464-9.614)0.323--
Histology: Adenocarcinoma vs adenocarcinoma with signet ring cell65.6 vs 00.368 (0.104-1.306)0.1080.376 (0.098-1.44)0.154
Pathologic grade: Poor vs moderate/well49.7 vs 65.31.232 (0.401-3.786)0.715--
T stage: T1-3 vs T477.0 vs 30.60.144 (0.039-0.534)0.0010.166 (0.041-0.672)0.012
N stage: N0 vs N+73.8 vs 39.20.216 (0.058-0.807)0.0130.432 (0.103-1.822)0.253